Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Feb;81(2):293-295.
doi: 10.1136/annrheumdis-2021-221252. Epub 2021 Sep 23.

Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series

Caoilfhionn M Connolly  1 , Teresa Po-Yu Chiang  2 , Brian J Boyarsky  2 , Jake A Ruddy  2 , Mayan Teles  2 , Jennifer L Alejo  2 , Allan Massie  2 , William A Werbel  3 , Ami A Shah  1 , Lisa Christopher-Stine  1 , Jacqueline Garonzik-Wang  2 , Dorry L Segev  4   5 , Julie J Paik  1
Affiliations
Observational Study

Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series

Caoilfhionn M Connolly et al. Ann Rheum Dis. 2022 Feb.
No abstract available

Keywords: COVID-19; autoimmune diseases; vaccination.

PubMed Disclaimer

Conflict of interest statement

Competing interests: DLS, MD PhD, has the following financial disclosures: consulting and speaking honoraria from Sanofi, Novartis, CSL Behring, Jazz Pharmaceuticals, Veloxis, Mallincrodt, Thermo Fisher Scientific.Lisa Christopher-Stine has the following financial disclosures: consultant fees from Janssen, Boehringer-Ingelheim, Mallinckrodt, EMD-Serono, Allogene and ArgenX.

References

    1. Connolly CM, Boyarsky BJ, Ruddy JA et al. Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series. Ann Intern Med. 2021. May 25. doi: 10.7326/M21-1451. Epub ahead of print. - DOI - PMC - PubMed
    1. Ruddy JA, Connolly CM, Boyarsky BJ, et al. High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseasesAnnals of the Rheumatic Diseases Published Online First: 24 May 2021. doi: 10.1136/annrheumdis-2021-220656 - DOI - PMC - PubMed
    1. Curtis JR, Johnson SR, Anthony DD et al. American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2. Arthritis Rheumatol. 2021. Jun 15. doi: 10.1002/art.41877. Epub ahead of print. - DOI - PMC - PubMed
    1. Higgins V, Fabros A, Kulasingam V, et al. Quantitative Measurement of Anti-SARS-CoV-2 Antibodies: Analytical and Clinical Evaluation. Journal of Clinical Microbiology. 2021;59(4). - PMC - PubMed
    1. Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients. JAMA. 2021. - PMC - PubMed

Publication types

MeSH terms